Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenic vascular tumors.

Jeffery L Kutok1, Christopher D M Fletcher

  • 1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

Seminars in Diagnostic Pathology
|August 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1 :: RELA Fusion in Pediatric Proliferative Fasciitis.

The American journal of surgical pathology·2026
Same author

Malignant vascular neoplasms of the distal female genital tract: a series of 19 cases emphasizing unusual features and diagnostic challenges.

Histopathology·2026
Same author

Atypical Vulvovaginal Postradiation Vascular Lesion: A Distinctive, Benign Mimic of Angiosarcoma Characterized in a Series of 15 Patients.

The American journal of surgical pathology·2026
Same author

Dedifferentiated Solitary Fibrous Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Characterization of 25 Cases.

The American journal of surgical pathology·2025
Same author

Cutaneous Hemangioma With Epithelioid Features Harboring TPM3/4::ALK Fusions : A Distinct Entity or a Molecular Variant of Epithelioid Hemangioma?

The American journal of surgical pathology·2025
Same author

A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation.

Molecular cell·2025
Same journal

Update on the molecular pathology of the distinctive giant cell, fibro-osseous and bone forming lesions of the jaws.

Seminars in diagnostic pathology·2026
Same journal

Update on the molecular pathology and classification of odontogenic cysts and tumours.

Seminars in diagnostic pathology·2026
Same journal

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026
Same journal

When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses.

Seminars in diagnostic pathology·2026
Same journal

Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.

Seminars in diagnostic pathology·2026
Same journal

Recent advances in genetic predisposition to primary testicular tumors.

Seminars in diagnostic pathology·2026
See all related articles

Splenic vascular tumors are rare, often benign. However, splenic angiosarcoma is aggressive. This overview covers diagnosis and differential diagnosis of these spleen tumors.

Area of Science:

  • Pathology
  • Oncology
  • Vascular Biology

Background:

  • Splenic vascular tumors are uncommon, frequently benign incidental findings.
  • Splenic angiosarcoma presents aggressively, often with acute symptoms.
  • Vascular tumors exhibit diverse endothelial and lymphatic differentiation with overlapping morphology.

Purpose of the Study:

  • To describe the diagnosis and differential diagnosis of splenic vascular tumors.
  • To address challenges in analyzing these tumors due to small case numbers.

Main Methods:

  • Literature review and synthesis of current understanding.
  • Analysis of morphologic features and diagnostic categories.

Main Results:

  • Splenic vascular tumors range from benign to malignant.

Related Experiment Videos

  • Morphologic overlap exists between diagnostic categories.
  • Angiosarcoma represents an aggressive malignant subset.

    • Conclusions:

    • Accurate diagnosis and differentiation are crucial for patient management.
    • Further research with larger cohorts is needed to better define these tumors.